These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 12610748)
1. Determinants for drug prescribing to children below the minimum licensed age. 't Jong GW; Eland IA; Sturkenboom MC; van den Anker JN; Stricker BH Eur J Clin Pharmacol; 2003 Feb; 58(10):701-5. PubMed ID: 12610748 [TBL] [Abstract][Full Text] [Related]
2. Risk factors for unlicensed and off-label drug use in children outside the hospital. Schirm E; Tobi H; de Jong-van den Berg LT Pediatrics; 2003 Feb; 111(2):291-5. PubMed ID: 12563053 [TBL] [Abstract][Full Text] [Related]
3. Unlicensed and off-label prescription of respiratory drugs to children. 't Jong GW; Eland IA; Sturkenboom MC; van den Anker JN; Strickerf BH Eur Respir J; 2004 Feb; 23(2):310-3. PubMed ID: 14979509 [TBL] [Abstract][Full Text] [Related]
4. Unlicensed and off-label drug use in a paediatric ward of a general hospital in the Netherlands. 't Jong GW; van der Linden PD; Bakker EM; van der Lely N; Eland IA; Stricker BH; van den Anker JN Eur J Clin Pharmacol; 2002 Jul; 58(4):293-7. PubMed ID: 12136376 [TBL] [Abstract][Full Text] [Related]
5. Off-label and unlicensed drug prescribing in three paediatric wards in Finland and review of the international literature. Lindell-Osuagwu L; Korhonen MJ; Saano S; Helin-Tanninen M; Naaranlahti T; Kokki H J Clin Pharm Ther; 2009 Jun; 34(3):277-87. PubMed ID: 19650250 [TBL] [Abstract][Full Text] [Related]
6. Rise in antiobesity drug prescribing for children and adolescents in the UK: a population-based study. Viner RM; Hsia Y; Neubert A; Wong IC Br J Clin Pharmacol; 2009 Dec; 68(6):844-51. PubMed ID: 20002078 [TBL] [Abstract][Full Text] [Related]
7. Off-label and unlicensed prescribing for children: have we made any progress? Waller DG Br J Clin Pharmacol; 2007 Jul; 64(1):1-2. PubMed ID: 17577389 [No Abstract] [Full Text] [Related]
8. Unlicensed and off-label use of medicines at a neonatology clinic in Italy. Dell'Aera M; Gasbarro AR; Padovano M; Laforgia N; Capodiferro D; Solarino B; Quaranta R; Dell'Erba AS Pharm World Sci; 2007 Aug; 29(4):361-7. PubMed ID: 17351821 [TBL] [Abstract][Full Text] [Related]
9. Prescription of methylphenidate to children and youth, 1990-1996. Miller AR; Lalonde CE; McGrail KM; Armstrong RW CMAJ; 2001 Nov; 165(11):1489-94. PubMed ID: 11762572 [TBL] [Abstract][Full Text] [Related]
10. Unlicensed and off label prescribing of drugs in general practice. McIntyre J; Conroy S; Avery A; Corns H; Choonara I Arch Dis Child; 2000 Dec; 83(6):498-501. PubMed ID: 11087285 [TBL] [Abstract][Full Text] [Related]
11. Unlicensed and off-label drug use in children: implications for safety. Choonara I; Conroy S Drug Saf; 2002; 25(1):1-5. PubMed ID: 11820908 [TBL] [Abstract][Full Text] [Related]
12. Why has antibiotic prescribing for respiratory illness declined in primary care? A longitudinal study using the General Practice Research Database. Ashworth M; Latinovic R; Charlton J; Cox K; Rowlands G; Gulliford M J Public Health (Oxf); 2004 Sep; 26(3):268-74. PubMed ID: 15454595 [TBL] [Abstract][Full Text] [Related]
13. Widespread off-label prescribing of topical but not systemic drugs for 350,000 paediatric outpatients in Stockholm. Ufer M; Rane A; Karlsson A; Kimland E; Bergman U Eur J Clin Pharmacol; 2003 Mar; 58(11):779-83. PubMed ID: 12634986 [TBL] [Abstract][Full Text] [Related]
14. Off-label and unlicensed drug use among neonatal intensive care units in Southern Italy. Laforgia N; Nuccio MM; Schettini F; Dell'Aera M; Gasbarro AR; Dell'Erba A; Solarino B Pediatr Int; 2014 Feb; 56(1):57-9. PubMed ID: 23937449 [TBL] [Abstract][Full Text] [Related]
15. [Medicines for children and "off-label use" 5 years after implementation of the Paediatric Regulation (EC) No 1901/2006. An interim analyis]. Afentaki A Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2014 Sep; 57(9):1111-9. PubMed ID: 25139386 [TBL] [Abstract][Full Text] [Related]
16. Unlicensed and off label drug use in acute lymphoblastic leukaemia and other malignancies in children. Conroy S; Newman C; Gudka S Ann Oncol; 2003 Jan; 14(1):42-7. PubMed ID: 12488291 [TBL] [Abstract][Full Text] [Related]
17. Pediatric Off-Label and Unlicensed Drug Use and Its Implications. Gore R; Chugh PK; Tripathi CD; Lhamo Y; Gautam S Curr Clin Pharmacol; 2017; 12(1):18-25. PubMed ID: 28322168 [TBL] [Abstract][Full Text] [Related]
18. Unlicensed and off label prescription of drugs to children: population based cohort study. 'T Jong GW; Eland IA; Sturkenboom MC; van den Anker JN; Stricker BH BMJ; 2002 Jun; 324(7349):1313-4. PubMed ID: 12039827 [No Abstract] [Full Text] [Related]
19. Licensing and labelling of drugs in a paediatric oncology ward. van den Berg H; Tak N Br J Clin Pharmacol; 2011 Sep; 72(3):474-81. PubMed ID: 21453298 [TBL] [Abstract][Full Text] [Related]
20. A survey of the use of off-label and unlicensed drugs in a Dutch children's hospital. 't Jong GW; Vulto AG; de Hoog M; Schimmel KJ; Tibboel D; van den Anker JN Pediatrics; 2001 Nov; 108(5):1089-93. PubMed ID: 11694685 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]